anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BioAtla · pitchdeck

BioAtla | Investor Presentation Deck | 43 slides

43 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

BioAtla | Investor Presentation Deck | 43 slides

BioAtla · 2023-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 57 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 5 slides 100% 5/5 slides 100% 5/5 slides · 36 hits
— 0/5 slides
40% 2/5 slides
— 0/5 slides
100% 5/5 slides 100% 5/5 slides Solution 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
33.3% 1/3 slides
— 0/3 slides
100% 3/3 slides · 4 hits
— 0/3 slides
Market Size 7 slides 100% 7/7 slides 100% 7/7 slides · 42 hits
— 0/7 slides
57.1% 4/7 slides · 6 hits 14.3% 1/7 slides 100% 7/7 slides · 20 hits 100% 7/7 slides Traction 9 slides 100% 9/9 slides 100% 9/9 slides · 50 hits
— 0/9 slides
55.6% 5/9 slides · 7 hits 11.1% 1/9 slides 100% 9/9 slides · 24 hits 66.7% 6/9 slides Roadmap 33 slides 100% 33/33 slides 100% 33/33 slides · 167 hits
— 0/33 slides
45.5% 15/33 slides · 17 hits 24.2% 8/33 slides 100% 33/33 slides · 50 hits 21.2% 7/33 slides

Slide inventory

43
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · ProblemLoop · Cost Of Inaction
02
other
Open slide detailBeat · ProblemLoop · Cost Of Inaction
03
The slide uses a linked-circle diagram to represent the interconnected nature of the company's value proposition.summarize
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide uses a grid layout to display 8 team members with headshots, names, titles, and logos of past companies.other
Open slide detailBeat · ProblemLoop · Cost Of Inaction
05
other
Open slide detailBeat · ProblemLoop · Cost Of Inaction
06
The slide uses a visual comparison between healthy cells (alkaline) and cancer cells (acidic) to demonstrate the selective binding mechanism.present_solution
Open slide detailBeat · Solution
07
The slide uses a three-column layout to categorize the platform's application, each with a corresponding antibody diagram.present_solution
Open slide detailBeat · Solution
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.plan_implementation
Open slide detailBeat · Solution
09
transition
Open slide detailBeat · Roadmap
10
The slide uses a structured list format to define the target market and unmet medical need.size_opportunity
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
11
The slide uses a waterfall plot for response and a spider plot for longitudinal tumor burden change.show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
12
Includes a spider plot for target lesion change and a Kaplan-Meier survival curve with a summary table.show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
13
Includes clinical trial design details (dosing regimens, patient counts, endpoints).show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
14
The slide uses a decision tree/process flow to map patient cohorts to clinical outcomes and subsequent trial progression.show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
15
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.show_traction
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
16
Includes detailed footnotes for data sources and medical abbreviations.size_opportunity
Open slide detailBeat · Market SizeLoop · Quick Win Big Bet
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.show_traction
Open slide detailBeat · Traction
18
The slide uses a process-oriented layout to describe clinical trial progression.plan_implementation
Open slide detailBeat · Traction
19
Data cut-off Jan 4, 2023. Includes partial and complete responses.show_traction
Open slide detailBeat · Traction
20
Includes waterfall plot (left) and spider plot (right) for patient response data.analyze_data
Open slide detailBeat · Roadmap
21
Includes specific clinical trial safety metrics and footnotes regarding data definitions.show_traction
Open slide detailBeat · Roadmap
22
The table displays specific drug administration schedules (mg/kg) for different cycle lengths and days.analyze_data
Open slide detailBeat · Roadmap
23
Includes abbreviations for indications (LMS, UPS, NSCLC) and trial design details.analyze_data
Open slide detailBeat · Roadmap
24
transition
Open slide detailBeat · Roadmap
25
The slide uses a combination of high-level market statistics and specific clinical benchmarks to define the target opportunity.size_opportunity
Open slide detailBeat · Roadmap
26
The chart highlights a specific patient case with a partial response (PR) and notes a suboptimal dose case.show_traction
Open slide detailBeat · Roadmap
27
Uses a 2x2 grid of metrics to frame the problem space.size_opportunity
Open slide detailBeat · Roadmap
28
The chart tracks % change in target lesions over time (weeks) for two specific patients.show_traction
Open slide detailBeat · Roadmap
29
The slide uses a funnel-like logic to narrow down from total prevalence to a specific addressable patient population for a 2L+ therapy.size_opportunity
Open slide detailBeat · Roadmap
30
The slide uses a table to present clinical trial outcomes (PR/CR) and safety data.show_traction
Open slide detailBeat · Roadmap
31
The slide outlines patient enrollment targets and treatment protocols for specific refractory patient populations.plan_implementation
Open slide detailBeat · Roadmap
32
The table compares dosing schedules for a clinical trial drug.analyze_data
Open slide detailBeat · Roadmap
33
BA3021 Ozuriftamab Vedotinanalyze_data
Open slide detailBeat · Roadmap
34
transition
Open slide detailBeat · Roadmap
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.compare_peers
Open slide detailBeat · Roadmap
36
The slide outlines a dose-escalation study (3+3 design) leading to RP2D selection and subsequent expansion cohorts.plan_implementation
Open slide detailBeat · Roadmap
37
transition
Open slide detailBeat · Roadmap
38
The slide uses a before-after-bridge style comparison between the problem (toxicity) and the solution (BA3182).present_solution
Open slide detailBeat · Roadmap
39
The slide uses a process flow diagram to illustrate dose escalation strategies (Accelerated vs Standard vs Priming).plan_implementation
Open slide detailBeat · Roadmap
40
The slide uses a two-column layout to represent 1H and 2H of 2023.plan_implementation
Open slide detailBeat · Roadmap
41
The slide uses a linked-circle diagram to represent the interconnected nature of their technology, pipeline, and financial health.summarize
Open slide detail
42
appendix
Open slide detail
43
The chart uses a log scale for the Y-axis. The legend defines the three regimens: Q2W, 2Q3W, and 3Q4W.analyze_data
Open slide detail